|
| Status |
Public on Nov 02, 2017 |
| Title |
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
mRNA expression in two different cell lines (DEV and G401) and two conditions (CLOFILIUM and DMSO) were assessed using the Illumina HiSeq2500 plateform in order to detect genes that are differentially expressed in CLOFILIUM condition compared to control (DMSO)
|
| |
|
| Overall design |
DEV and G401 cell lines were treated with CLOFILIUM and DMSO. mRNA were extracted 48 hours after treatment. 3 biological replicates were extracted for analysis.
|
| |
|
| Contributor(s) |
Bourdeaut F, Chauvin C, Andrianteranagna M |
| Citation(s) |
29141209 |
| |
| Submission date |
Aug 09, 2017 |
| Last update date |
May 15, 2019 |
| Contact name |
Mamy Jean de Dieu ANDRIANTERANAGNA |
| E-mail(s) |
mamy-jean-de-dieu.andrianteranagna@curie.fr
|
| Phone |
+33156246274
|
| Organization name |
Institut Curie
|
| Department |
Centre de Recherche
|
| Lab |
U900
|
| Street address |
26 rue d'Ulm
|
| City |
Paris |
| State/province |
Ile de France |
| ZIP/Postal code |
75005 |
| Country |
France |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (12)
|
|
| Relations |
| BioProject |
PRJNA397908 |
| SRA |
SRP115222 |
Less...
More...